Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Slade

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Vaccine|August 2, 2011
Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009S Elizabeth Williams, Nicola P Klein, Neal Halsey, et al.
The Pediatric Infectious Disease Journal|January 22, 2013
Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccinationBarbara A Pahud, S Elizabeth Williams, Cornelia L Dekker, et al.
Vaccine|September 7, 2011
Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccinationS Elizabeth Williams, Barbara A Pahud, Claudia Vellozzi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 23, 2023
Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM)Jeremy S McComish, Charlotte A Slade, Luke Buizen, et al.
Frontiers in Immunology|June 6, 2018
Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian AdultsCharlotte A Slade, Julian J Bosco, Tran Binh Giang, et al.
Frontiers in Immunology|April 8, 2020
Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte DeficienciesMahya Dezfouli, Sofia Bergström, Lillemor Skattum, et al.
Nature Communications|September 28, 2023
A common human MLKL polymorphism confers resistance to negative regulation by phosphorylationSarah E Garnish, Katherine R Martin, Maria Kauppi, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2020
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutationsTiziana Lorenzini, Manfred Fliegauf, Nils Klammer, et al.
Nature|November 8, 2023
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiencyTom Le Voyer, Audrey V Parent, Xian Liu, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Vaccine|August 2, 2011
Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009S Elizabeth Williams, Nicola P Klein, Neal Halsey, et al.
The Pediatric Infectious Disease Journal|January 22, 2013
Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccinationBarbara A Pahud, S Elizabeth Williams, Cornelia L Dekker, et al.
Vaccine|September 7, 2011
Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccinationS Elizabeth Williams, Barbara A Pahud, Claudia Vellozzi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 23, 2023
Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM)Jeremy S McComish, Charlotte A Slade, Luke Buizen, et al.
Frontiers in Immunology|June 6, 2018
Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian AdultsCharlotte A Slade, Julian J Bosco, Tran Binh Giang, et al.
Frontiers in Immunology|April 8, 2020
Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte DeficienciesMahya Dezfouli, Sofia Bergström, Lillemor Skattum, et al.
Nature Communications|September 28, 2023
A common human MLKL polymorphism confers resistance to negative regulation by phosphorylationSarah E Garnish, Katherine R Martin, Maria Kauppi, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2020
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutationsTiziana Lorenzini, Manfred Fliegauf, Nils Klammer, et al.
Nature|November 8, 2023
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiencyTom Le Voyer, Audrey V Parent, Xian Liu, et al.
Pageof 14